Science News : ESC 2012 : Sunday

Updated:Sep 27,2012
ESC12_WebMasthead  

ESC 2012 - Hot Lines I, 8-26-2012

ESC 2102 - Clinical Trial and Registr...


Select a study name to view presentation slides and summary slides as they become available.

Hot Line I – Late Breaking Trials on Prevention of Heart Failure:
 esc12_pure_sslide_photoPURE
Patterns of risk factor prevalence for CVD globally by urbanization, gender, and economic status of countries and individuals: The Prospective Urban Rural Epidemiologic (PURE) Study of 153,996 people from 628 communities in 17 countries  
Salim Yusuf, Hamilton, Ontario, Canada
Presentation slides  |  Summary slide
esc12_defacto-pslides_photo DeFACTO
Determination of Fractional Flow Reserve by Anatomic Computed Tomographic Angiography  
James Min, Los Angeles, Calif., U.S.
Presentation slides  |  Summary slide
esc12_altitude_sslide_photoALTITUDE
ALiskiren Trial In Type 2 Diabetes Using cardio-renal Endpoints
Hans Henrik Parving, Copenhagen, Denmark  
Summary slide
esc12_triolgy-acs_sslide_photo

TRILOGY-ACS
Prasugrel versus clopidodrel for patients with Unstable Angina/NSTEMI who are medically managed without revascularization
Matthew Roe, Durham, N.C., U.S.
Summary slide

esc12_paramount_sslide_photoPARAMOUNT
Efficacy and Safety of LCZ696, a First-in-Class Angiotensin Receptor Neprilysin Inhibitor, in Patients with Heart Failure and Preserved Ejection Fraction: Primary Results from the PARAMOUNT Study
Scott Solomon, Boston, Mass., U.S.
Summary slide
esc12_aldo-dhf_sslide_photoAldo-DHF
Aldosterone Receptor Blockade in Diastolic Heart Failure
Burkert Mathias Pieske, Graz, Austria
Summary slide


Clinical Trial and Registry Updates I – Updates on Prevention and Markers
 PRoFESS
Impact of resting heart rates on recurrent stroke, cardiovascular outcomes, disability and cognitive decline in 20.165 patients after ischemic stroke
Michael Boehm, Homburg/Saar, Germany  
 
esc12_clarify_pslides-photoCLARIFY
Women and men with stable coronary artery disease have similar cardiovascular outcomes: observations from an international prospective cohort of 30 977 patients from 45 countries
Philippe Gabriel Steg, Paris, France
Presentation slides 
 HPS2-THRIVE
Treatment of HDL to Reduce the Incidence of Vascular Events
Jane Armitage, Oxford, Great Britian
Presentation slides
esc12_tra2p-timi50_pslides_photo TRA 2°P-TIMI 50 Trial
Vorapaxar for Secondary Prevention after Myocardial Infarction
Benjamin Morgan Scirica, Boston, Mass., U.S.
Presentation slides
 esc12_diaz_pure_pslides_photoPURE
Prevalence, awareness, treatment and control of hypertension in 600 urban and rural communities from 17 high, middle and low income countries: Results from the PURE (Prospective Urban Rural Epidemiology)
Rafael Diaz, Rosario, Argentina
Presentation slides
 

 



Connect with AHA Science News

Follow AHAScience on Twitter (opens in new window)
Like AHA Science News on Facebook (opens in new window)

Network with over 31,000 Heart and Stroke Professionals

  • Connect with others around the world
  • Share and discuss articles by prominent heart and stroke researchers
     
    Join the AHA's Professional Online Network at networking.americanheart.org    Login to AHA's Professional Online Network at networking.americanheart.org

AHA Science News on YouTube



Subscribe to AHA's Science News Channel (opens in new window)
on YouTube for exclusive, late-breaking coverage of over 200 video interviews, panel discussions, welcome messages and more.